Background: Obstructive sleep apnea (OSA) is associated with dyslipidemia. However, the
effects of continuous positive airway pressure (CPAP) treatment on lipid profiles are unclear …

Background Obstructive sleep apnea syndrome (OSAS) is an independent risk factor for
development of dyslipidemia. Continuous positive airway pressure (CPAP) is the first-line …

Purpose Dyslipidemia is considered as one mechanism causing cardiovascular sequelae in
obstructive sleep apnea (OSA). Continuous positive airway pressure (CPAP) can reduce …

Background and aim Obstructive sleep apnea (OSA) is an independent risk factor for
dyslipidemia. The current study examined the effects of positive airway pressure (PAP) …

Continuous positive airway pressure (CPAP) provides a well‐documented symptomatic
relief for most patients with obstructive sleep apnea (OSA); however, its effect on …

Rationale: Dyslipidemia is common in Obstructive Sleep Apnea (OSA). Postprandial
lipidemia (PPL) is a strong marker of cardiovascular risk. Evidence that OSA treatment …

Abstract Background and aim Continuous Positive Airway Pressure (CPAP) is the most
effective therapy for symptomatic obstructive sleep apnoea (OSA). However, uncertainty …

Abstract Obstructive Sleep Apnoea (OSA) is a common disorder in adults. Its hallmark is
repetitive episodes of partial or complete obstruction of the upper airway during sleep …

Study Objective: Patients with obstructive sleep apnea (OSA) frequently exhibit higher rates
of dyslipidemia, a risk factor for cardiovascular and cerebrovascular disorders. Treatment for …

Background The effect of obesity and medication on the relationship between obstructive
sleep apnoea (OSA) and lipidaemia and systemic inflammation is not fully understood for …